UC Denver Diabetes Research Center

加州大学丹佛分校糖尿病研究中心

基本信息

  • 批准号:
    10392976
  • 负责人:
  • 金额:
    $ 134.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

CENTER OVERVIEW PROJECT SUMMARY/ABSTRACT The University of Colorado Denver (UC Denver) is world renowned for basic, translational, and clinical diabetes research and treatment of both Type 1 and Type 2 diabetes (T1D and T2D), and their related complications. The proposed University of Colorado Diabetes Research Center (UC Denver DRC) will strengthen diabetes research in Colorado by providing: 1) state-of-the-art research technologies and specialized resources to maximize effective and innovative research; 2) access to patient samples and data; 3) enrichment programs, education and seminar series to the diabetes community; and 4) by attracting new scientists into the diabetes field through the Pilot and Feasibility program. These objectives will be realized by providing improved infrastructure and access to specialized reagents and resources, and an environment that promotes scientific interactions, research discoveries, and progress towards diabetes treatment and cures. The UC Denver DRC will be primarily located on the rapidly growing Anschutz Medical Campus (AMC) in Aurora, Colorado where the majority of the UC Denver clinical and research departments are located. This unique multi-hospital and academic campus configuration allows for a broad diabetes research base, which currently includes 88 basic, translational, and clinical scientific investigators across 17 departments and divisions at UC AMC who currently bring diabetes/diabetes-related direct cost grant support totaling > $65 million in individual grants and >$14 million in center and training grants. Drs. Lori Sussel, PhD. and Jane Reusch, MD bring together complementary areas of scientific backgrounds and expertise to oversee the organization and scientific focus of the UC Denver DRC. We will implement four Biomedical Research Cores to provide cutting-edge technologies in Clinical Resources (fully integrated databases for tracking of study participants, bio-samples and data), Tissue Procurement and Processing (rodent tissue and islet isolation, human islet and tissue procurement, histology services, cell culture bank), Diabetes Modeling (human stem cell-derived in vitro cell and organoid models, gene editing), and Cell and Tissue Analysis (advanced microscopy, flow cytometry, specialized CyTOF and MIBI reagents for the diabetes community). The UC Denver DRC will also establish a Pilot and Feasibility Program to recruit young faculty into diabetes and diabetes-related research, and encourage established investigators from other fields to enter the diabetes field. The Dean of the UC Denver School of Medicine has pledged to supplement the P&F budget by $100,000 each year to promote an increased diabetes research presence on campus. Finally, the UC Denver DRC Enrichment Program will promote the interaction between diabetes researchers at UC AMC by providing seminar forums for exchange of research findings, providing opportunities to form collaborative relationships, and encouraging cross-pollination between the diverse diabetes communities.
中心概述

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LORI SUSSEL其他文献

LORI SUSSEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LORI SUSSEL', 18)}}的其他基金

PTPN2 mutations affect islet beta cell susceptibility in T1D
PTPN2 突变影响 T1D 中胰岛β细胞的易感性
  • 批准号:
    10398956
  • 财政年份:
    2020
  • 资助金额:
    $ 134.43万
  • 项目类别:
PTPN2 mutations affect islet beta cell susceptibility in T1D
PTPN2 突变影响 T1D 中胰岛β细胞的易感性
  • 批准号:
    10028702
  • 财政年份:
    2020
  • 资助金额:
    $ 134.43万
  • 项目类别:
UC Denver Diabetes Research Center
加州大学丹佛分校糖尿病研究中心
  • 批准号:
    10646143
  • 财政年份:
    2020
  • 资助金额:
    $ 134.43万
  • 项目类别:
PTPN2 mutations affect islet beta cell susceptibility in T1D
PTPN2 突变影响 T1D 中胰岛β细胞的易感性
  • 批准号:
    10614497
  • 财政年份:
    2020
  • 资助金额:
    $ 134.43万
  • 项目类别:
PTPN2 mutations affect islet beta cell susceptibility in T1D
PTPN2 突变影响 T1D 中胰岛β细胞的易感性
  • 批准号:
    10174923
  • 财政年份:
    2020
  • 资助金额:
    $ 134.43万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10392977
  • 财政年份:
    2020
  • 资助金额:
    $ 134.43万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10646144
  • 财政年份:
    2020
  • 资助金额:
    $ 134.43万
  • 项目类别:
Long non-coding RNAs in Islet Cell Biology
胰岛细胞生物学中的长非编码 RNA
  • 批准号:
    9212938
  • 财政年份:
    2017
  • 资助金额:
    $ 134.43万
  • 项目类别:
Long non-coding RNAs in Islet Cell Biology
胰岛细胞生物学中的长非编码 RNA
  • 批准号:
    9507845
  • 财政年份:
    2017
  • 资助金额:
    $ 134.43万
  • 项目类别:
Regulation of pancreatic cell fate
胰腺细胞命运的调节
  • 批准号:
    9300634
  • 财政年份:
    2016
  • 资助金额:
    $ 134.43万
  • 项目类别:

相似海外基金

B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 134.43万
  • 项目类别:
    Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 134.43万
  • 项目类别:
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
  • 批准号:
    MR/Y001273/1
  • 财政年份:
    2024
  • 资助金额:
    $ 134.43万
  • 项目类别:
    Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
  • 批准号:
    478933
  • 财政年份:
    2023
  • 资助金额:
    $ 134.43万
  • 项目类别:
    Operating Grants
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
  • 批准号:
    10655219
  • 财政年份:
    2023
  • 资助金额:
    $ 134.43万
  • 项目类别:
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
  • 批准号:
    10760885
  • 财政年份:
    2023
  • 资助金额:
    $ 134.43万
  • 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
  • 批准号:
    10582053
  • 财政年份:
    2023
  • 资助金额:
    $ 134.43万
  • 项目类别:
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
  • 批准号:
    2889164
  • 财政年份:
    2023
  • 资助金额:
    $ 134.43万
  • 项目类别:
    Studentship
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
  • 批准号:
    490663
  • 财政年份:
    2023
  • 资助金额:
    $ 134.43万
  • 项目类别:
    Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
  • 批准号:
    488982
  • 财政年份:
    2023
  • 资助金额:
    $ 134.43万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了